Administering intramuscular injections: How does research translate into practice over time in the mental health setting?

Nurse Education Today

Volumn 35, Issue 4, 2015, Pages 620-624

  Wynaden, Dianne ^a   Tohotoa, Jenny ^a   AL Omari, Omar ^b   Happell, Brenda ^c   Heslop, Karen ^a   Barr, Lesley ^d   Sourinathan, Vijay ^d  

^a CURTIN UNIVERSITY   (Australia)

^b JERASH UNIVERSITY   (Jordan)

^c CENTRAL QUEENSLAND UNIVERSITY   (Australia)

^d State Forensic Mental Health Services ^*  (Australia)

Author keywords

Evidence based practice; Injection techniques; Intramuscular injections; Mental health; Nursing education

Indexed keywords

ADULT; CLINICAL NURSING RESEARCH; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EDUCATION; EVIDENCE BASED NURSING; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MASS COMMUNICATION; MENTAL HEALTH; MIDDLE AGED; NURSING; NURSING STAFF; PROCEDURES; PSYCHIATRIC NURSING; QUESTIONNAIRE; STANDARDS; YOUNG ADULT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CLINICAL NURSING RESEARCH; CROSS-SECTIONAL STUDIES; DIFFUSION OF INNOVATION; EVIDENCE-BASED NURSING; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MENTAL HEALTH; MIDDLE AGED; NURSING STAFF; PSYCHIATRIC NURSING; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84925625294     PISSN: 02606917     EISSN: 15322793     Source Type: Journal    
DOI: 10.1016/j.nedt.2014.12.008     Document Type: Article

References (58)

1. Artioli G., Finotto S., Chiesi I., Bigi E. Criteria used by nurses in choosing the site for intramuscular injections: custom or scientific evidence?. Prof. Inferm. 2002, 55(4):218-223.
2. Bond D., Pratoomsri W., Yatham L. Depot antipsychotic medications in bipolar disorder: a review of the literature. Acta Psychiatr. Scand. 2007, 116(Suppl. 434):3-16.
3. Boyd A., Deford L., Mares J., Leary C., Garris J., Dagohoy C., Yao J. Improving the success rate of gluteal intramuscular injections. Pancreas 2013, 42(5):878-882. 10.1097/MPA.0b013e318279d552.
4. Burbridge B. Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections. Can. Assoc. Radiol. J. 2007, 58(2):72-75.
5. Cañas F., Möller H.J. Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review. Expert Opin. Drug Saf. 2010, 9(5):683-697. 10.1517/14740338.2010.506712.
6. Carter-Templeton H., McCoy T. Are we on the same page?: a comparison of intramuscular injection explanations in nursing fundamental texts. Medsurg. Nurs. 2008, 17(4):237-240.
7. Chan V., Colville J., Persaud T., Buckley O., Hamilton S., Torreggiani W. Intramuscular injections into the buttocks: are they truly intramuscular?. Eur. J. Radiol. 2006, 58(3):480-484.
8. Cocoman A., Murray J. Intramuscular injections: a review of best practice for mental health nurses. J. Psychiatr. Ment. Health Nurs. 2008, 15:424-434.
9. Cocoman A., Murray J. Recognizing the evidence and changing practice on injection sites. Br. J. Nurs. 2010, 19(18):1170-1174.
10. Cornwall J. Are nursing students safe when choosing gluteal intramuscular injection locations?. Australas Med. J. 2011, 4(6):315-321. 10.4066/AMJ.2011764.
11. Cox A., Emmerson B., Collyer B., Scott J. Why change injection sites for depot antipsychotic medication?. Aust. N. Z. J. Psychiatry 2012, 46(8):794.
12. Davis J. The use of depot medications in the treatment of schizophrenia. Am. J. Psychiatry 2010, 167(2):125-126. 10.1176/appi.ajp.2009.09111676.
13. Dayananda L., Belaval V.V., Raina A., Chandana R. Intended intramuscular gluteal injections: are they truly intramuscular?. J. Postgrad. Med. 2014, 60(2):175-178. 10.4103/0022-3859.132334.
14. Donaldson C., Green J. Using the ventrogluteal site for intramuscular injections. Nurs. Times 2005, 101(16):36-38.
15. Dougherty L., Lister S. The Royal Marsden Hospital Manual of Clinical Nursing Procedures 2011, Wiley-Blackwell, London. 8th edition.
16. Farchaus Stein K. Evidence-based decision making in psychiatric and mental health nursing. J. Am. Psychiatr. Nurs. Assoc. 2013, 19(2):61-62. 10.1177/1078390313486617.
17. Feetam C., White J. Guidance on the Administration to Adults of Oilbased Depot and Other Long-acting Intramuscular Antipsychotic Injections 2011, College of Mental Health Pharmacy, Hull. 3rd edition.
18. Fleischhacker W.W. Second-generation antipsychotic long-acting injections: systematic review. Br. J. Psychiatry Suppl. 2009, 52:S29-S36. 10.1192/bjp.195.52.s29.
19. Gerrish K., Clayton J. Promoting evidence-based practice: an organizational approach. J. Nurs. Manag. 2004, 12(2):114-123.
20. Gilsenan I. A practical guide to giving injections. Nurs. Times 2000, 96(33):43-44.
21. Glasgow R.E., Emmons K.M. How can we increase translation of research into practice? Types of evidence needed. Annu. Rev. Public Health 2007, 28:413-433.
22. Gray R., Spilling R., Burgess D., Newey T. Antipsychotic long-acting injections in clinical practice: medication management and patient choice. Br. J. Psychiatry 2009, 195:s51-s56. 10.1192/bjp.195.52.s51.
23. Greenway K. Using the ventrogluteal site for intramuscular injection. Nurs. Stand. 2004, 18(25):39-42.
24. Hough D., Lindenmayer J.P., Gopal S., Melkote R., Lim P., Herben V., Eerdekens M. Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(6):1022-1031. 10.1016/j.pnpbp.2009.05.014.
25. Hunter J. Intramuscular injection techniques. Nurs. Stand. 2008, 22(24):35-40.
26. Kane J.M., Garcia-Ribera C. Clinical guideline recommendations for antipsychotic long-acting injections. Br. J. Psychiatry 2009, 195:S63-S67. 10.1192/bjp.195.52.s63.
27. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373(9657):31-41.
28. Leucht S., Tardy M., Komossa K., Heres S., Kissling W., Salanti G., Davis J.M. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 2012, 379(9831):2063-2071.
29. Mabbott V., Robinson M., Segrave A. Australian Statistics on Medicine (978-1-74186-084-9) 2011, Australian Bureau of Statistics, Canberra.
30. Malkin B. Are techniques used for intramuscular injection based on research evidence?. Nurs. Times 2008, 104(50/51):48-51.
31. Mathews M., Muzina D. Atypical antipsychotics: new drugs, new challenges. Cleve. Clin. J. Med. 2007, 74(8):597-606.
32. McGarvey M. Intramuscular injections: a review of nursing practice for adults. All Irel. J. Nurs. Midwifery 2001, 1(5):185-193.
33. Meyer A., Floyd S. Intramuscular Injections-What's Best Practice? Why is There Such a Gap Between What is Taught in Nursing Schools About the Best Sites End Technique for Intramuscular Injections and What Actually Happens in Practice? 2007, Nursing New Zealand, Kai Tiaki.
34. Mitchell A.J., Hardy S.A. Screening for metabolic risk among patients with severe mental illness and diabetes: a national comparison. Psychiatr. Serv. 2013, 10:1060-1063.
35. Mitragotri S. Immunization without needles. Nat. Rev. Immunol. 2005, 5(12):905-916.
36. Moores P., Allan P. Affecting change through continuing education: improving vaccine administration technique. J. Contin. Educ. Nurs. 2012, 43(9):395-400.
37. Nasrallah H., Newcomer J. Atypical antipsychotic and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J. Clin. Psychopharmacol. 2004, 24(5 Suppl 1):S7-S14.
38. Nisbet A. Intramuscular gluteal injections in the increasingly obese population: retrospective study. Br. Med. J. 2006, 332:637-638.
39. Ohaeri J., Akanji A. Metabolic syndrome in severe mental disorders. Metab. Syndr. Relat. Disord. 2011, 9:91-98.
40. Perry A., Potter P. Clinical Nursing Skills and Techniques 2004, Mosby, St Louis. 5th ed.
41. Pullen R.L. Administering medication by the Z-track method. Nursing 2005, 35(7):24.
42. Reynolds G., Kirk S. Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms. Pharmacol. Ther. 2010, 125(1):169-179. 10.1016/j.pharmthera.2009.10.010.
43. Riordan H.J., Antonini P., Murphy M. Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications. Clinical 2011, 4(5):292-301.
44. Rodger M., King L. Drawing up and administering intramuscular injections: a review of literature. J Adv Nurs 2000, 31(3):574-582.
45. Royal Australian and New Zealand College of Psychiatrists Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust. N. Z. J. Psychiatry 2005, 39(1-2):1-30.
46. Schooler N.R. Relapse and rehospitalization: comparing oral and depot antipsychotics. J. Clin. Psychiatry 2003, 64(Suppl. 16):14-17.
47. Small S. Preventing sciatic nerve injury from intramuscular injections: literature review. J. Adv. Nurs. 2004, 47(3):287-296.
48. Tarnow K., King N. Intradermal injections: bevel up or bevel down. Appl. Nurs. Res. 2004, 17(4):275-282.
49. Taylor D. Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review. Br. J. Psychiatry 2009, 195:S13-S19.
50. Walsh L., Brophy K. Staff nurses' sites of choice for administering intramuscular injections to adult patients in the acute care setting. J. Adv. Nurs. 2011, 67(5):1034-1040. 10.1111/j.1365-2648.2010.05527.x.
51. Wilson D. Side effects may include lawsuits. N. Y. Times 2010, (October 2).
52. Winslow E.H. The right site for IM injections. Am. J. Nurs. 1996, 96(4):53.
53. Wynaden D.G., Landsborough I., Chapman R., McGowan S., Lapsley J., Finn M. Establishing best practice guidelines for administration of intra-muscular injections in the adult: a systematic review of the literature. Contemp. Nurse 2005, 20(2):267-277.
54. Wynaden D., Landsborough I., McGowan S., Baigmohamad Z., Finn M., Pennebaker D. Best practice guidelines for the administration of intramuscular injections in the mental health setting. Int. J. Ment. Health Nurs. 2006, 15:195-200. 10.1111/j.1447-0349.2006.00423.x.
55. Zaybak A., Gneş U., Tamsel S., Khorshid L., Eşer I. Does obesity prevent the needle from reaching muscle in intramuscular injections?. J. Adv. Nurs. 2007, 58(6):552-556.
56. Zimmermann P. Revisiting IM injections: the ventrogluteal site is the safest for intramuscular injections. Am. J. Nurs. 2010, 110(2):60-61.
57. Zuckerman J. The importance of injection vaccine into muscle: different clients need different needle size. Br. Med. J. 2000, 321(7271):1237-1238.
58. Zuckerman J. Importance of needle size for effective intramuscular delivery of vaccines. Br. J. Gen. Pract. 2000, 50(458):753.